IRIS
CALZETTA, Luigino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.121
NA - Nord America 6.250
EU - Europa 3.338
SA - Sud America 2.018
AF - Africa 489
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.079
SG - Singapore 3.833
BR - Brasile 1.598
IE - Irlanda 1.084
CN - Cina 954
HK - Hong Kong 870
VN - Vietnam 862
SE - Svezia 479
ZA - Sudafrica 380
IT - Italia 367
NL - Olanda 363
DE - Germania 251
AR - Argentina 173
FI - Finlandia 166
RU - Federazione Russa 165
IN - India 113
AT - Austria 96
BD - Bangladesh 94
GB - Regno Unito 94
ID - Indonesia 76
MX - Messico 72
CO - Colombia 58
EC - Ecuador 57
CA - Canada 55
IQ - Iraq 51
FR - Francia 45
EE - Estonia 38
UA - Ucraina 37
PK - Pakistan 34
VE - Venezuela 33
PY - Paraguay 31
TR - Turchia 31
CL - Cile 30
JP - Giappone 28
CI - Costa d'Avorio 24
BE - Belgio 22
MA - Marocco 22
PL - Polonia 22
UZ - Uzbekistan 22
ES - Italia 21
KR - Corea 18
PE - Perù 18
EG - Egitto 16
AE - Emirati Arabi Uniti 13
IL - Israele 13
LT - Lituania 13
SA - Arabia Saudita 13
UY - Uruguay 12
AZ - Azerbaigian 10
JO - Giordania 10
KE - Kenya 10
AU - Australia 9
DZ - Algeria 9
KG - Kirghizistan 9
TN - Tunisia 9
TW - Taiwan 9
AL - Albania 8
DO - Repubblica Dominicana 8
IR - Iran 8
PT - Portogallo 8
BO - Bolivia 7
CH - Svizzera 7
MY - Malesia 7
NI - Nicaragua 7
OM - Oman 7
BG - Bulgaria 6
HN - Honduras 6
KZ - Kazakistan 6
NP - Nepal 6
NZ - Nuova Zelanda 6
RO - Romania 6
HR - Croazia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BY - Bielorussia 4
HU - Ungheria 4
KW - Kuwait 4
LU - Lussemburgo 4
PA - Panama 4
RS - Serbia 4
AO - Angola 3
BB - Barbados 3
BH - Bahrain 3
BW - Botswana 3
CR - Costa Rica 3
ET - Etiopia 3
JM - Giamaica 3
LB - Libano 3
MK - Macedonia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
SI - Slovenia 2
SV - El Salvador 2
Totale 19.214
Salva come PNG Salva come JPEG
Città #
Singapore 1.865
Chandler 1.262
Dublin 1.074
Hong Kong 863
Ashburn 750
Santa Clara 438
Dallas 393
Johannesburg 363
Ho Chi Minh City 329
Boardman 323
Princeton 255
Beijing 249
Hanoi 179
Helsinki 148
Des Moines 143
Munich 136
São Paulo 124
Los Angeles 90
Wilmington 89
Moscow 84
Vienna 79
Shanghai 72
Columbus 64
New York 60
Ann Arbor 58
Rio de Janeiro 57
Rome 50
Parma 47
Council Bluffs 42
Haiphong 39
Tallinn 38
Chicago 37
Milan 36
Buffalo 32
Da Nang 31
The Dalles 31
Belo Horizonte 30
Marseille 30
Guangzhou 28
Curitiba 27
Tianjin 27
Hefei 25
Abidjan 24
Nuremberg 24
Brooklyn 23
Hải Dương 23
Brussels 22
Brasília 21
Phoenix 21
Porto Alegre 21
Seattle 21
Tashkent 21
Tokyo 21
Biên Hòa 20
Bologna 20
Dhaka 20
Salvador 20
Warsaw 20
Bremen 19
Fortaleza 19
Fremont 19
Jakarta 19
London 19
Campinas 18
Denver 18
Guayaquil 18
Ninh Bình 18
Redmond 18
Seoul 18
Toronto 18
Buenos Aires 17
Goiânia 17
Mexico City 16
Naples 16
Pune 16
Quito 16
Chennai 15
Houston 15
Norwalk 15
Baghdad 14
Bắc Ninh 14
Jinan 13
Rockville 13
Asunción 12
Duque de Caxias 12
Frankfurt am Main 12
Manaus 12
Medellín 12
Montreal 12
St Louis 12
Bengaluru 11
Boston 11
Ribeirão Preto 11
Stockholm 11
Zhengzhou 11
Amman 10
Baku 10
Erbil 10
Guarulhos 10
Lima 10
Totale 11.046
Salva come PNG Salva come JPEG
Nome #
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 218
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 171
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD 160
Small airways in asthma: from bench-to-bedside 156
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients 156
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea 137
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients 130
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom 127
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 120
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study 116
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 112
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume 112
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System 111
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review 108
A 6MWT index to predict O-2 flow correcting exercise induced SpO(2) desaturation in ILD 107
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence 106
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system 105
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 105
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 101
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 100
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review 99
Advances with glucocorticoids in the treatment of asthma: state of the art 97
A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD 96
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD 95
Analysis of exhaled breath fingerprints and volatile organic compounds in COPD 94
A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ) 92
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines 91
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination 87
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 87
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement 86
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD 85
Cardiovascular disease in copd 85
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 83
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 83
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 82
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD 81
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis 81
Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease 81
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms 81
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania” 81
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study 80
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 78
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis 77
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab 77
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? 76
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review 75
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 75
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies 75
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study 74
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 74
ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 73
Onset of action of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in patients with COPD 73
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine 72
The interplay between diabetes mellitus and chronic obstructive pulmonary disease. An overview 71
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials 71
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 70
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma 70
SMART for the treatment of asthma: A network meta-analysis of real-world evidence 70
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses 70
Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma 69
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? 69
Allergy in adolescent population (14-18 years) living in Campania region (southern Italy). A multicenter study 69
Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations 68
Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma 68
Post-COVID-19 exaggerated exertional tachycardia: Relationship with pulmonary and cardiac sequelae 67
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment 67
Corrigendum to “Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat” [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342] (Pulmonary Pharmacology & Therapeutics (2025) 88, (S1094553924000580), (10.1016/j.pupt.2024.102342)) 66
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update 66
Optimizing drug delivery in COPD: The role of inhaler devices 66
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 66
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 66
ANTI-INFLAMMATORY PROFILE OF N-ACETYLCYSTEINE IN HUMAN BRONCHI STIMULATED WITH LIPOPOLYSACCHARIDE 65
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 65
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients 65
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment 64
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways 64
Unmet needs and relationship between general practitioners (GPS) and allergists living in Campania region (Southern Italy) 64
Challenges in treating patients with comorbid asthma and bronchiectasis 63
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 63
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate plus vilanterol for the treatment of asthma 63
Emerging drugs for chronic obstructive pulmonary disease 63
Sex differences in COPD management 63
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 63
The impact of comorbidities on severe asthma 63
The possible concomitant use of aeroallergen and food panels for skin prick testing might enhance the risk of generalized allergic reactions in children 63
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 62
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 62
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile 62
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations 62
Experimental glucocorticoid receptor agonists for the treatment of asthma: A systematic review 62
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? 62
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat 61
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement 61
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 61
SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis 61
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 61
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem 60
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD 60
TSLP Inhibitors for Asthma: Current Status and Future Prospects 60
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 60
Totale 8.321
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 3 0 19 31 20 5 5
2021/20221.115 1 10 2 20 76 39 257 75 46 3 37 549
2022/20233.925 507 310 228 257 277 453 48 275 1.373 27 134 36
2023/20241.411 100 160 56 65 141 258 102 81 63 99 102 184
2024/20255.400 49 329 453 271 541 510 206 237 757 560 338 1.149
2025/20267.587 947 1.282 1.808 1.464 1.943 143 0 0 0 0 0 0
Totale 19.735